Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
作者信息
Lemay A, Maheux R, Jean C, Faure N
出版信息
Prog Clin Biol Res. 1986;225:157-73.
PMID:3097663
Abstract
摘要
相似文献
1
2
Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Prog Clin Biol Res. 1986;225:211-25.
3
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.鼻内或皮下注射促黄体生成素释放激素激动剂抑制卵巢功能在子宫内膜异位症治疗中的疗效。
Am J Obstet Gynecol. 1988 Feb;158(2):233-6. doi: 10.1016/0002-9378(88)90128-7.
4
5
The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).促黄体生成素释放激素激动剂疗法治疗子宫内膜异位症的效果（荷兰的经验）
Prog Clin Biol Res. 1986;225:201-10.
6
Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis.与皮下注射布舍瑞林植入剂相比，经鼻给予布舍瑞林治疗子宫内膜异位症的疗效。
Fertil Steril. 1989 Jul;52(1):27-30. doi: 10.1016/s0015-0282(16)60783-5.
7
Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Clin Reprod Fertil. 1986 Oct;4(5):329-36.
8
Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
Int J Fertil Menopausal Stud. 1995 Mar-Apr;40(2):106-11.
9
[Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Geburtshilfe Frauenheilkd. 1994 Oct;54(10):569-73. doi: 10.1055/s-2007-1022341.
10
[Androgens and other hormones in buserelin therapy].
Geburtshilfe Frauenheilkd. 1991 Feb;51(2):140-2. doi: 10.1055/s-2007-1023690.
Zotero 插件